Cibus, Inc. (NASDAQ:CBUS – Free Report) – Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Cibus in a research report issued on Friday, March 21st. HC Wainwright analyst A. Dayal expects that the company will post earnings of ($0.66) per share for the quarter. HC Wainwright has a “Buy” rating and a $25.00 price target on the stock. The consensus estimate for Cibus’ current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus’ Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.
Separately, Canaccord Genuity Group lowered their price objective on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd.
Cibus Price Performance
Shares of Cibus stock opened at $2.05 on Monday. The company has a 50 day simple moving average of $2.33 and a two-hundred day simple moving average of $3.31. The firm has a market cap of $54.23 million, a PE ratio of -0.09 and a beta of 2.04. Cibus has a 1 year low of $1.80 and a 1 year high of $23.18.
Cibus (NASDAQ:CBUS – Get Free Report) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). The business had revenue of $1.21 million for the quarter, compared to analysts’ expectations of $1.13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%.
Hedge Funds Weigh In On Cibus
Institutional investors and hedge funds have recently made changes to their positions in the business. FMR LLC lifted its stake in Cibus by 16.9% in the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock worth $12,757,000 after purchasing an additional 566,328 shares during the last quarter. Granby Capital Management LLC increased its holdings in shares of Cibus by 300.0% in the fourth quarter. Granby Capital Management LLC now owns 200,000 shares of the company’s stock worth $556,000 after buying an additional 150,000 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Cibus by 933.3% in the 4th quarter. Renaissance Technologies LLC now owns 127,100 shares of the company’s stock valued at $353,000 after acquiring an additional 114,800 shares during the last quarter. State Street Corp grew its holdings in shares of Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company’s stock worth $1,002,000 after purchasing an additional 93,236 shares during the last quarter. Finally, Certior Financial Group LLC purchased a new position in shares of Cibus in the fourth quarter worth $236,000. Institutional investors own 33.81% of the company’s stock.
Cibus Company Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Further Reading
- Five stocks we like better than Cibus
- What Are Dividend Achievers? An Introduction
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- With Risk Tolerance, One Size Does Not Fit All
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Market Cap Calculator: How to Calculate Market Cap
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.